Skip to main content
Category

Lab

Epigenetics and Genomics LaboratoryFundingGenome Biology and GeneticsLabMedia ReleasesNews & EventsResearch

Perkins researchers granted funds to advance epigenetic research

By | Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetics, Lab, Media Releases, News & Events, Research

Two researchers at the Harry Perkins Institute of Medical Research have been awarded separate grants totalling $3.6million in federal government funding to better understand and treat diseases. Perkins CEO, Prof…

Chronic Kidney DiseaseKidney DiseaseLabMedia ReleasesMolecular Endocrinology and PharmacologyNews & EventsResearchResearch Area

Phase 3 drug trial for rare chronic kidney disease achieves key milestone

By | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research Area

Biopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…

Cardiovascular DiseaseCardiovascular DiseaseCardiovascular Science and Diabetes ProgramDiabetesFundingNews & EventsResearch

Federal government supports new treatment to clear blocked arteries

By | Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Diabetes, Funding, News & Events, Research

A Western Australian medical research team developing a new treatment for cardiovascular disease has received $2,147,254 in Federal government funding to develop a first-ever drug to clear blocked arteries. The…